XML 54 R20.htm IDEA: XBRL DOCUMENT
v3.25.2

Income Taxes | 12 Months Ended
--- | ---
Jun. 29, 2025
Income Tax Disclosure [Abstract] |
Income Taxes | Income Taxes Significant components of the income tax provision are as follows:
| Years Ended
| June 29, 2025 |  | June 30, 2024 |  | July 2, 2023
| (in thousands)
Current provision (benefit): |  |  |  |  |
Federal | $ | (1,942) |  |  | $ | 11,774 |  |  | $ | 976 |
State | 1,125 |  |  | 161 |  |  | 1,572 |
Foreign | 176 |  |  | — |  |  | — |
Current income tax (benefit) expense | (641) |  |  | 11,935 |  |  | 2,548 |
Deferred provision (benefit): |  |  |  |  |
Federal | (12,880) |  |  | (14,246) |  |  | (3,145) |
State | 131 |  |  | 2,514 |  |  | (1,463) |
Foreign | 26 |  |  | — |  |  | — |
Deferred income tax benefit | (12,723) |  |  | (11,732) |  |  | (4,608) |
Income tax (benefit) expense | $ | (13,364) |  |  | $ | 203 |  |  | $ | (2,060) |
A reconciliation of the U.S. federal statutory tax rate to the Company’s effective tax rate is as follows:
| Years Ended
| June 29, 2025 |  | June 30, 2024 |  | July 2, 2023
Tax at U.S. statutory rates | 21.0 | % |  | 21.0 | % |  | 21.0 | %
State income taxes, net of federal tax benefit | 3.4 |  |  | (8.1) |  |  | (0.2) |
Non-deductible impairment charge | (1.4) |  |  | - |  |  | (16.8) |
Valuation allowance change | (16.8) |  |  | (28.5) |  |  | (0.2) |
Non-deductible compensation | (0.1) |  |  | (0.6) |  |  | (2.1) |
Excess tax benefit/shortfalls from stock-based compensation | (0.2) |  |  | (11.9) |  |  | (1.7) |
Tax credits | 0.3 |  |  | 16.9 |  |  | 2.7 |
Enhanced deductions | - |  |  | 11.8 |  |  | 2.6 |
Other, net | 0.1 |  |  | (4.0) |  |  | (0.9) |
Effective tax rate | 6.3 | % |  | (3.4 | %) |  | 4.4 | %
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of the Company's deferred income tax assets (liabilities) are as follows:
| June 29, 2025 |  | June 30, 2024
| (in thousands)
Deferred income tax assets: |  |  |
Loss and carryforwards | $ | 17,508 |  |  | $ | 8,096 |
Accrued expenses and reserves | 4,949 |  |  | 3,146 |
Inventory | 4,366 |  |  | 5,417 |
Stock-based compensation | 2,613 |  |  | 1,767 |
Deferred compensation | 7,242 |  |  | 6,815 |
Operating lease liability | 29,002 |  |  | 30,763 |
Other intangibles | 20,604 |  |  | — |
Gross deferred income tax assets | 86,284 |  |  | 56,004 |
Less: Valuation allowance | (40,581) |  |  | (4,868) |
Deferred tax assets, net | 45,703 |  |  | 51,136 |
Deferred income tax liabilities: |  |  |
Other intangibles | — |  |  | (10,693) |
Tax in excess of book depreciation | (25,409) |  |  | (31,206) |
Operating lease right-of-use asset | (26,973) |  |  | (28,639) |
Deferred tax liabilities | (52,382) |  |  | (70,538) |
Net deferred income tax liabilities | $ | (6,679) |  |  | $ | (19,402) |
At June 29, 2025, the Company had $22.0 million of indefinite lived federal net operating losses, $110.4 million of state net operating loss carryforwards, some of which will begin to expire in fiscal 2026 to the extent not utilized and $5.4 million of foreign net operating loss carryforwards, which will begin to expire in fiscal 2034 if not utilized. At June 29, 2025, the Company’s federal charitable contribution carryforwards were $21.9 million, which will begin to expire in fiscal 2027 if not utilized. At June 29, 2025, the Company’s research and development and work opportunity credit carryforwards were $0.6 million and $0.1 million, respectively, which will both begin to expire in fiscal 2045 if not utilized. The Company evaluates the realizability of its deferred tax assets on a quarterly basis and establishes valuation allowances when it is more likely than not that all or a portion of a deferred tax asset may not be realized. In completing this evaluation, the Company considers available positive and negative evidence. Such evidence includes historical operating results, the existence of cumulative earnings and losses in the most recent fiscal years, taxable income in prior carryback year(s) if permitted under the tax law, the time period over which our temporary differences will reverse, the implementation of feasible and prudent tax planning strategies, and expectations for future pre-tax operating income. Estimating future taxable income is inherently uncertain and requires judgment. Deferred tax assets are reduced by a valuation allowance if, based on the weight of this evidence, it is more likely than not that all or a portion of the recorded deferred tax assets will not be realized in future periods. During fiscal 2025, the Company completed a detailed analysis of future taxable income, focused on the scheduling of temporary differences that are expected to reverse in periods where the Company anticipates taxable income. Due to the goodwill and intangible impairment charge recorded during fiscal 2025, deferred tax liabilities were reduced to an amount whereby the lack of sufficient reversing taxable temporary differences is significant evidence considered by the Company in recording a $35.9 million valuation allowance. At the time of the impairment, the Company was in a three-year cumulative loss position and had not identified any tax planning strategies to support the deferred tax asset realizability. Additionally, the impairment charge reduced previously available deferred tax liabilities that had supported the realization of deferred tax assets. During fiscal 2024, the Company recorded valuation allowances of $1.7 million relating to certain state and foreign jurisdictions. As of June 30, 2024, the Company had valuation allowances of $4.9 million primarily related to certain state and foreign net operating losses. The Company files income tax returns in the U.S. federal jurisdiction, various state jurisdictions, and various foreign countries. Fiscal 2022, fiscal 2023, and fiscal 2024 remain subject to U.S. federal examination. Due to nonconformity with the U.S. federal statute of limitations for assessment, certain states remain open from fiscal 2021. The Company's foreign income tax filings from fiscal 2018 forward are open for examination by its respective foreign tax authorities, mainly Canada and Brazil. The Company is not currently under examination by federal, state or foreign taxing jurisdictions. The Company’s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. At June 29, 2025, the Company has an unrecognized tax benefit, including accrued interest and penalties, included within the “Other liabilities” line item in the consolidated balance sheets, of approximately $3.4 million all of which if fully recognized would impact our effective tax rate. The Company believes that $0.3 million of the unrecognized tax positions will be resolved over the next twelve months. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
| Years Ended
| June 29, 2025 |  | June 30, 2024 |  | July 2, 2023
| (in thousands)
Beginning balance | $ | 2,780 |  |  | $ | 1,724 |  |  | $ | 1,374 |
Increases on tax positions for prior years | 72 |  |  | 1,100 |  |  | 30 |
Increases on tax positions for current year | 209 |  |  | 387 |  |  | 320 |
Settlements | (166) |  |  | - |  |  | - |
Statute of limitation expirations | (135) |  |  | (431) |  |  | - |
Ending balance | $ | 2,760 |  |  | $ | 2,780 |  |  | $ | 1,724 |

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income tax. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/740/tableOfContent Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration